Sagimet Biosciences Inc.
SGMT | NASDAQ
$11.21
+$0.41 (+3.80%)
Sep 22, 2026, 11:22 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.75 | -3.10 | -3.54 | -11.56 | -14.50 | -31.27 |
PEG Ratio | -0.42 | 0.59 | -0.33 | -0.45 | -0.13 | 1.54 |
PS Ratio | n/a | n/a | 49.31 | n/a | n/a | n/a |
PB Ratio | 1.72 | 0.91 | 1.08 | -1.89 | -2.23 | -2.60 |
P/FCF Ratio | -4.19 | -3.32 | -4.15 | -14.44 | -16.29 | -33.96 |
P/OCF Ratio | -4.19 | -3.32 | -4.15 | -14.44 | -16.29 | -33.96 |
OCF/S Ratio | n/a | n/a | -1.19K | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0 |
Quick Ratio | 22.82 | 34.30 | 17.09 | 6.21 | 24.04 | 35.99 |
Current Ratio | 22.82 | 34.30 | 17.09 | 6.21 | 24.04 | 35.99 |
Asset Turnover | n/a | n/a | 0.02 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -45.82% | -29.25% | -30.61% | 16.31% | 15.44% | 8.37% |
Return on Assets | -43.82% | -28.43% | -28.82% | -92.33% | -41.40% | -16.49% |
Return on Invested Capital | -51.04% | -34.93% | -33.73% | -111.37% | -41.82% | -16.97% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -1.39K% | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -1.39K% | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -1.54K% | n/a | n/a | n/a |
FCF Margin | n/a | n/a | -1.19K% | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -1.39K% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SGMT